This site is intended for health professionals only

Published on 28 January 2008

Share this story:
Twitter
LinkedIn

French firm sets up potent-molecule plant

teaser

French-based biotechnology company Novasep has installed and validated a new industrial HPAI
 (highly potent active ingredient) manufacturing plant in its facility at Le Mans, France.

The move follows the establishment of a second kilo-lab for highly potent substance synthesis and
 purification.

In a press release, the company said the 
€8m investment had been made to meet growing demand for
 multipurpose chemistry and purification of highly potent molecules in a highly confined current Good Manufacturing Practices environment.

The firm said the value of combined investments at the Le Mans site was now €50m.

Novasep provides synthesis support services for highly potent molecules, from early stage phases of development through to commercial 
quantities.

Novasep



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn